Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MRNA-1365 by Moderna for Human Metapneumovirus Infections: Likelihood of Approval
MRNA-1365 is under clinical development by Moderna and currently in Phase I for Human Metapneumovirus Infections. According to GlobalData, Phase...
Data Insights
MRNA-1365 by Moderna for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
MRNA-1365 is under clinical development by Moderna and currently in Phase I for Respiratory Syncytial Virus (RSV) Infections. According to...